ArticleAdvances in therapy2026
Retrospective Assessment of Food Noise Changes After Initiation of Injectable Semaglutide for Weight Management in the USA: The INFORM Survey.
Article in Advances in therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Digital Behavioral Infrastructure for Glucagon-Like Peptide-1 Pharmacotherapy: Viewpoint on Persistence, Tolerability, and Postcessation Durability.Journal of medical Internet research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introduction'Food noise', persistent and intrusive thoughts about food that can disrupt daily life, has emerged as a concern for individuals with obesity, and often impacts quality of life. Recent anecdotal reports suggest that glucagon-like peptide-1 receptor agonists, such as semaglutide, may reduce food noise. Research is needed to characterize food noise in real-world populations and to quantify the impact of weight management treatments on its presentation and intensity. We present findings from the INFORM survey, which assessed perceived changes in food noise among US adults receiving injectable semaglutide for weight management.
methodsIndividuals recruited from Numerator's opinion panel were asked to complete 22 multiple choice questions, including the five-item Food Noise Questionnaire (FNQ).
resultsIn total, 550 people participated in the survey. Respondents were predominantly women (86%) and white (79%), with a mean age of 53 years (standard deviation 10.8). Most had baseline body mass index (BMI) ≥ 30 kg/m
conclusionFurther prospective, longitudinal research is warranted to fully characterize these apparent promising effects of semaglutide for weight management, and their relationship with clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.